Alaunos Therapeutics Statistics
Total Valuation
TCRT has a market cap or net worth of $6.17 million. The enterprise value is $3.95 million.
Important Dates
The next estimated earnings date is Monday, March 30, 2026, after market close.
| Earnings Date | Mar 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TCRT has 2.23 million shares outstanding. The number of shares has increased by 10.36% in one year.
| Current Share Class | 2.23M |
| Shares Outstanding | 2.23M |
| Shares Change (YoY) | +10.36% |
| Shares Change (QoQ) | +30.23% |
| Owned by Insiders (%) | 22.02% |
| Owned by Institutions (%) | 6.12% |
| Float | 1.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 982.00 |
| Forward PS | n/a |
| PB Ratio | 2.08 |
| P/TBV Ratio | 2.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 659.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.92
| Current Ratio | 2.92 |
| Quick Ratio | 2.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -145.65% and return on invested capital (ROIC) is -92.12%.
| Return on Equity (ROE) | -145.65% |
| Return on Assets (ROA) | -69.99% |
| Return on Invested Capital (ROIC) | -92.12% |
| Return on Capital Employed (ROCE) | -145.31% |
| Weighted Average Cost of Capital (WACC) | -2.63% |
| Revenue Per Employee | $6,000 |
| Profits Per Employee | -$4.03M |
| Employee Count | 1 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.63% in the last 52 weeks. The beta is -1.25, so TCRT's price volatility has been lower than the market average.
| Beta (5Y) | -1.25 |
| 52-Week Price Change | +69.63% |
| 50-Day Moving Average | 3.24 |
| 200-Day Moving Average | 3.04 |
| Relative Strength Index (RSI) | 43.39 |
| Average Volume (20 Days) | 14,677 |
Short Selling Information
The latest short interest is 52,250, so 2.34% of the outstanding shares have been sold short.
| Short Interest | 52,250 |
| Short Previous Month | 37,856 |
| Short % of Shares Out | 2.34% |
| Short % of Float | 3.00% |
| Short Ratio (days to cover) | 1.03 |
Income Statement
In the last 12 months, TCRT had revenue of $6,000 and -$4.03 million in losses. Loss per share was -$2.28.
| Revenue | 6,000 |
| Gross Profit | -910,000 |
| Operating Income | -4.07M |
| Pretax Income | -4.03M |
| Net Income | -4.03M |
| EBITDA | -4.07M |
| EBIT | -4.07M |
| Loss Per Share | -$2.28 |
Full Income StatementBalance Sheet
The company has $1.94 million in cash and n/a in debt, with a net cash position of $1.94 million or $0.87 per share.
| Cash & Cash Equivalents | 1.94M |
| Total Debt | n/a |
| Net Cash | 1.94M |
| Net Cash Per Share | $0.87 |
| Equity (Book Value) | 2.80M |
| Book Value Per Share | 1.27 |
| Working Capital | 1.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.91 million and capital expenditures -$97,000, giving a free cash flow of -$3.01 million.
| Operating Cash Flow | -2.91M |
| Capital Expenditures | -97,000 |
| Free Cash Flow | -3.01M |
| FCF Per Share | -$1.35 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -67,883.33% |
| Pretax Margin | -67,083.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TCRT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.36% |
| Shareholder Yield | -10.36% |
| Earnings Yield | -68.31% |
| FCF Yield | -51.02% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 18, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 18, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
TCRT has an Altman Z-Score of -347.5 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -347.5 |
| Piotroski F-Score | 3 |
